'Cherry red spot' in a patient with Tay-Sachs disease: case report.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Arquivos Brasileiros de Oftalmologia

• Publication date

  2009-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1590/S0004-27492009000400019PMID 19820796
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases

  2010cited by this paper
• High-throughput screening for human lysosomal beta-N-Acetyl hexosaminidase inhibitors acting as pharmacological chaperones.

  2007cited by this paper
• The "cherry red" spot.

  2007cited by this paper
• Production of Recombinant β-Hexosaminidase A, a Potential Enzyme for Replacement Therapy for Tay-Sachs and Sandhoff Diseases, in the Methylotrophic Yeast Ogataea minuta

  2007cited by this paper
• Pyrimethamine as a Potential Pharmacological Chaperone for Late-onset Forms of GM2 Gangliosidosis*

  2007cited by this paper
• Effective gene therapy in an authentic model of Tay-Sachs-related diseases

  2006cited by this paper
• "Cherry-red spot" or "perifoveal white patch"?

  2005cited by this paper
• Neuro-ophthalmology of late-onset Tay–Sachs disease (LOTS)

  2004cited by this paper
• Metabolic diseases

  2003influential reference
• Substrate reduction therapy in mouse models of the glycosphingolipidoses.

  2003cited by this paper
• Cherry red spot.

  2002cited by this paper
• Observations on time course changes of the cherry red spot in a patient with Tay-Sachs disease

  2000cited by this paper
• Rare and Fatal Disease of Infancy.

  year unknowncited by this paper

• Failure of Allogeneic Transplant to Correct Sialidosis Despite Early Diagnosis and Full Donor Engraftment of Non‐Carrier Leucocytes

  2026cites this paper
• Eye is a window to systemic pathology: cherry-red spot to diagnose Tay-Sachs disease

  2024cites this paper
• Doença de Tay-Sachs: relato de caso

  2023cites this paper
• A fuzzy rule based machine intelligence model for cherry red spot disease detection of human eyes in IoMT

  2022cites this paper
• A misleading presentation of juvenile Tay Sachs disease.

  2020cites this paper
• Clinical, biochemical, and molecular findings in a Colombian patient with Tay-Sachs disease

  2020cites this paper
• Tay-Sachs disease: case report

  2020cites this paper
• Lysosomal Storage Disorders

  2019cites this paper
• Tay-Sachs disease

  2019cites this paper
• Metabolic diseases and the eye in childhood

  2019cites this paper
• Study of Genetics Mutations in HEXA Gene for Induced Tay-Sachs Disease in Human, Tabriz, Iran

  2017cites this paper
• Clinical, biochemical, and molecular findings in a Colombian patient with Tay-Sachs disease.

  2016cites this paper
• Toddler with retinal defects. . .psychomotor regression. Sandhoff disease.

  2015cites this paper
• Immunomodulatory Effects of Intracranial Gene Therapy in Feline Sandhoff Disease

  2014cites this paper
• Manifestaciones oftalmológicas de los errores innatos del metabolismo

  2014cites this paper